Abstract The human tongue muscle hyoglossus (HG) is active in oromotor behaviors encompassing a wide range of tongue movement speeds. Here we test the hypothesis that the human HG is composed of ''uncommon'' myosin heavy-chain (MHC) isoforms MHCembryonic, MHCneonatal, and MHCslow tonic as has been reported for other head and neck muscles active during kinematically diverse behaviors. Following reaction of human HG with antibodies specific for MHCI, MHCIIA, MHCII, MHCembryonic, MHCextraocular, MHCneonatal, and MHCslow tonic, only antibodies to MHCI, MHCIIA, and MHCII label more than occasional muscle fibers. These antibodies describe five phenotypes with prevalence MHCIIA [ MHCI [ MHCI-IIX [ MHCI-IIA [ MHCIIX. In MHC composition, the human HG is thus similar to human appendicular muscles and many human head and neck muscles but different from human masseter and extraocular muscles which contain five or more MHC isoforms.
isoforms or for hybridization of MHC isoforms in individual fibers. In our recent study of the extrinsic human tongue muscle styloglossus [27] we did not find evidence for MHCembryonic, MHCneonatal, or MHCslow tonic in more than occasional fibers or evidence for a large percent of MHCI-II hybrid fibers (\25% fibers phenotype MHCI-II). The presence of uncommon MHC has not been investigated in other human tongue muscles. Here we test the hypothesis that despite activation of the human HG during kinematically diverse oromotor behaviors, the human HG does not contain appreciable uncommon MHCembryonic, MHCeom, MHCneonatal, and MHCslow tonic.
Materials and Methods

Subjects and Tissue Preparation
Tissue for immunohistochemical study was taken from the left or right HG within 9 h postmortem from three subjects with no known neuromuscular disease: a 63-year-old female (designated HG1), an 80-year-old male (HG2), and a 56-year-old male (HG3) (all from the Emory University School of Medicine Body Donor Program, EUSMBDP; all tissue used in this study is IRB-exempt). HG tissue was taken proximal to the decussation of HG with the styloglossus and proximal to the entry of the HG into the tongue body to avoid the inclusion of fibers of other tongue muscles which interdigitate with the HG in the posterior tongue body [e.g., 28]. Tissue was sampled from both anterior and posterior regions of the HG to minimize spatial bias. Additional tissue for immunohistochemical control studies and for gel electrophoresis was obtained within 12 h postmortem from a human fetal tongue (designated FT; National Disease Research Interchange), from the HG (HG4, tissue sampled as above) and biceps brachii (BB) of an 86-year-old female, and from the medial rectus (MR) of a 63-year-old female (all from EUSMBDP). All tissue samples were immediately mounted onto tongue depressors with OCT tissue tek (Sakura Finetek USA, Torrance, CA), quick-frozen in isopentane cooled by liquid nitrogen, and stored at -80°C.
Immunohistochemical Methods
For each muscle sample, serial 12-lm-thick cross sections were cut on a cryostat at -23°C and mounted onto gelatinsubbed slides. Because histologic techniques do not allow confident determination of MHC composition and MHC phenotype in muscles containing hybrid fibers and uncommon MHC, serial sections of each muscle were reacted with the following antibodies (Ab) to MHC: Ab 2F7 (Developmental Studies Hybridoma Bank, DSHB, Iowa City, IA), which in rats and likely baboons is specific for MHCIIA [29] ; Ab 4A6 (DSHB), which in rabbits and likely baboons and humans is specific for MHCeom [18, 30] ; Ab A4.74 (DSHB), which in humans is reported to be specific for MHCIIA [19, 31, 32] or MHCIIA [ MHCIIX [26, 33] ; Ab A4.84 (DSHB), which in humans is specific for MHCI(bcardiac) [31, 34] ; Ab F1.652 (DSHB), which in humans is specific for MHCembryonic [35] ; Ab NCLMHCd (Vector Laboratories, Burlingame, CA), which in mammals is likely specific for MHCembryonic [36] ; Ab MY-32 (Sigma-Aldrich, St Louis, MO), which in rats and humans reacts with MHCII isoforms and likely MHCneonatal [37, 38] ; Ab N2.261 (DSHB), which in humans reacts with MHCI, MHCacardiac, MHCIIA, and MHCeom [31, 39] or is thought to be specific for MHCneonatal [20] ; Ab NCL-MHCn (Vector Laboratories, Burlingame, CA), which in mammals is specific for MHCneonatal [19, 40] ; Ab S46 (DSHB), which reacts with putative MHCslow tonic in adult human muscle spindles and human extraocular muscles but does not cross react with MHCacardiac or MHCI(bcardiac) in adult catarrhine primate muscle [41] ; and Ab SC-71 (ATCC), which in humans is thought to be specific for MHCIIA [34, 42] , to label MHCIIA [ MH-CIIX [19, 33] or to label MHCIIA and MHCIIX [43] . Ab MY-32 was reacted at a dilution of 1:400; Abs 2F7, SC-71, and S46 were reacted at a dilution of 1:25; and Abs A4.74, A4.84, F1.652, NCL-MHCd, NCL-MHCn, and N2.261 were reacted at a dilution of 1:5. On additional serial sections the anti-laminin Ab D-18 (DSHB, 1:5 dilution) was coreacted with Abs MHC-MHCd, NCL-MHCn, and S46 to aid in muscle fiber visualization [26] .
Tissue was reacted following the protocol of Eason et al. [44] . Briefly, tissue sections were incubated in a blocking solution composed of 2% normal goat serum, 0.03% Triton-X, and 0.1 M Tris-HCl (T-NGS) at room temperature for 1 h, followed by incubation overnight with primary antibody in blocking solution in a humidity chamber at -4°C. Tissue was then washed in Tris-HCl buffer and incubated with secondary antibody (for Ab 4A6, peroxidase-conjugated goat IGM fraction to mouse immunoglobulins, Capel dilution 1:100; for all other Abs, peroxidase-conjugated goat IGG fraction to mouse immunoglobulins, Capel dilution 1:100) for 1 h at room temperature. A standard DAB reaction was used to visualize label (0.5 mg DAB/ml, 0.1 M PBS, 0.03% H 2 O 2 ). Slides were then washed with H 2 O for 1 min, dehydrated, and coverslipped in permount.
Tissue sections were viewed on an Olympus BX51 microscope at 1009, 2009, and 4009 magnification. Images were collected with Neurolucida software (Microbrightfield, Burlington, VT) and a MicroFire digital microscope camera (Optronics, Goleta, CA) and stored onto computer (Dell Optiplex GX270, 1280 9 1024 pixel resolution).
Tests of Ab Specificity and Ab Criteria for MHC Phenotype Classification
In the light of discordant reports of MHC Ab specificities in human muscle (see above), we conducted control studies to minimize the possibility of false-positive attribution of MHC due to Ab cross-reactivity. We reacted Abs with human biceps brachii muscle as a positive control for MHCI, MHCIIA, and MHCIIX and a negative control for MHCembryonic, MHCeom, MHCneonatal, and MHCslow tonic [39, 45] ; human fetal tongue as a positive control for MHCembryonic and MHCneonatal; and human MR as a positive control for MHCeom and MHCslow tonic [16, 18] . For some MHC we also compared reaction of two Abs on control and HG tissue to determine optimal immunohistochemical criteria for HG MHC phenotype characterization. Results of these control studies are described by MHC isoform.
MHCembryonic: Abs NCL-MHCd and F1.652
Abs NCL-MHCd and F1.652 labeled muscle fibers in human fetal tongue but did not label muscle fibers in adult human BB (Fig. 1b, e ; data shown for NCL-MHCd). Both Abs have been shown to react with an early developmental MHC, likely MHCembryonic [35, 36] . Reaction with either Ab NCL-MHCd or Ab F1.652 is here considered positive for MHCembryonic.
MHCeom: Ab 4A6
Ab 4A6 labeled muscle fibers in human MR but did not label any muscle fibers in the BB (Fig. 1c, f) . Here reaction with Ab 4A6 is considered positive for MHCeom.
MHCneonatal: Abs NCL-MHCn and N2.261
Ab NCL-MHCn labeled muscle fibers in fetal human tongue but did not label muscle fibers in adult BB (Fig. 1) . In contrast, Ab N2.261 labeled muscle fibers in human fetal tongue, Ab MY-32?/NCL-MHCn-(i.e., MHCII) fibers in BB (Fig. 1g) , and MHCII and Ab A4.84?/MY-32-/NCLMHCn-(i.e., MHCI) fibers in HG (Fig. 2e) . Because of cross reaction of Ab N2.261 with MHCII and MHCI isoforms [see also 18, 31, 39] , in this study, reaction with Ab NCL-MHCn is considered positive for MHCneonatal.
MHCslow tonic: Ab S46
Ab S46 labeled muscle fibers in EOM and muscle spindles in BB but did not label extrafusal muscle fibers in BB (data not shown; see also [41] ). Here reaction with Ab S46 is considered positive for MHCslow tonic.
MHCII: Abs MY-32 and A4.74
Abs MY-32 and A4.74 reacted with control BB (Fig. 1j, k) . Among HG fibers used in this study, weak, moderate, or strong reaction of either Ab was present in 945 muscle fibers (Fig. 2i, j ). Of these, 930 fibers (98.4%) were labeled with both Abs, but 15 fibers (1.6%) were labeled exclusively by Ab MY-32 ( Fig. 2) . Absence of Ab NCL-MHCn reaction in all HG fibers positive for Ab MY-32 suggests that Ab MY-32 labeling is not due to cross-reactivity with MHCneonatal. We therefore attribute the reaction of Ab MY-32 but not Ab A4.74 in these fibers to the greater sensitivity of Ab MY-32 for MHCIIX. In our study, a reaction profile of Ab MY-32?/Ab NCL-MHCn-is considered positive for MHCII without distinction of MHCIIA and MHCIIX.
MHCIIA: Abs SC-71 and 2F7
Abs SC-71 and 2F7 each labeled a subset of MHCII fibers in the BB (Fig. 1h, i ). Among HG fibers used in this study, Abs SC-71 and Ab 2F7 had similar patterns of reaction: of 682 fibers labeled by either Ab, 676 fibers (99.1%) were labeled by both Abs (Fig. 2f, g ). Four fibers (0.6%) were labeled by Ab 2F7 but not by Ab SC-71, and two fibers (0. Based on our control studies, we used Abs 4A6, A4.84, F1.652, MY-32, NCL-MHCd, NCL-MHCn, SC-71, S46, and 2F7 to determine HG MHC composition.
MHC Composition, Phenotype Analysis, and Statistics
MHC Composition
Most Abs labeled either many or no muscle fibers, but with some Abs only occasional fibers were labeled. For reactions with these Abs we counted every labeled muscle fiber and expressed this number relative to the total number of muscle fibers in our samples, determined for each subject on a serial section reacted with Abs NCL-MHCn and D-18 (Physical Fractionator software, Stereo Investigator, Microbrightfield, Burlington, VT; second estimated Schmitz-Hof CE [46] of 0.029 for HG1, 0.027 for HG2, and 0.037 for HG3). Perimeters of fibers positive for Abs F1.652, NCL-MHCd, NCL-MHCn, and S46 were traced at 4009 magnification in Neurolucida software (Microbrightfield; MicroFire digital microscope camera, Dell Optiplex GX270, 1280 9 1024 pixel resolution), and diameter measurements were calculated by the program (the few positive fibers sectioned obliquely were not measured). The diameter measurement used is defined as the feret max of the fiber, which is calculated as the maximum distance between two parallel lines that enclose the muscle fiber (Neurolucida).
MHC Phenotype Analysis
Hyoglossus muscle fiber MHC phenotype was determined by analyzing 1349 muscle fibers from three individuals (475 from HG1, 464 from HG2, 410 from HG3). For each individual, fibers were sampled from anterior and posterior HG regions in fascicles selected for consistent morphology through all tissue sections. Even with this criterion, a few fibers could not be followed in all sections and thus were excluded from analysis. Individual fibers were scored as positive or negative for MHCI, MHCIIA, MHCII(A/X), MHCembryonic, MHCeom, MHCneonatal, and MHCslow tonic, and MHC phenotype was determined based on reaction profile (Table 1) . Fiber perimeters were traced and fiber cross-sectional area, perimeter, and diameter were calculated in Neurolucida software.
Graphs of the distribution of MHC phenotypes and fiber measurements were generated in Statistica (v6, Statsoft, Inc., Tulsa, OK). Fiber counts per 1000 fibers were calculated for each phenotype. Ninety-five percent confidence intervals (CI) were estimated for the prevalence rates using exact methods based on the Poisson distribution. Repeatedmeasures analyses using mixed linear models were performed for perimeter, diameter, and area utilizing SAS Proc Mixed (v9, SAS Institute, Cary, NC). These models provide separate estimates of the means by phenotype. A compound symmetry variance-covariance form in repeated measurements was assumed for each outcome, and robust estimates of the standard errors of parameters were used to do statistical tests and construct 95% CI. The model-based means are unbiased with unbalanced and missing data so long as the missing data are noninformative (missing at random). Statistical tests were two-sided. A p value less than 0.05 was considered statistically significant.
Electrophoretic Immunoblotting
Tissue obtained from HG2, HG4, BB, MR, and FT was used for immunoblot tests of MHCembryonic, MHCneonatal, and MHCslow tonic. Approximately 15-50 mg of muscle tissue was placed in 300 ll of nondenaturing lysis buffer (50 mM Tris, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, with 0.02% NaN 3 and 0.1% protease inhibitors) and homogenized for 30 s with a Tissuemiser at 15,000 rpm in an ice bath and cleared by centrifugation at 14,000 g for 10 min. Protein content was assayed by bicinchronic acid assay (BCA; Pierce, Rockford, IL) according to the manufacturer's instructions. Protein was separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) through a 7. . Migration of MHC was determined by running a 204-kDa molecular weight standard (Bio-Rad kaleidoscope prestained standard; Bio-Rad Laboratories, Hercules, CA) on each gel. Gels were transferred to a PVDF membrane using a semi-wet transfer system. Membranes were blocked for 60 min in 0.5% blocking buffer prior to incubation with primary Abs F1.652, NCL-MHCd, NCL-MHCn, N2.261, or S46 (1:500 dilution). Well-rinsed membranes were conjugated with secondary Alexa Fluor 680 goat antimouse IgG (1:2,000 dilution) and visualized using the Odyssey Infrared Imaging System (Li-Cor, Lincoln, NE).
Results
Immunohistochemical Identification of MHC Isoforms
MHCI, MHCIIA, MHCII Abs 2F7, A4.84, MY-32, and SC-71 each labeled many fibers in all HG samples (Fig. 2) . MHCembryonic, MHCeom, MHCneonatal, and MHCslow tonic Abs 4A6, F1.652, NCL-MHCd, NCL-MHCn, and S46 labeled few or no fibers in HG tissue sections (Fig. 2) . No fibers were positive for Ab 4A6 (anti-MHCeom) and few were positive for Ab F1.652 or Ab NCL-MHCd (antiMHCembryonic, \0.14% fibers, Table 2 ) or for Ab S46 (anti-MHCslow tonic,\0.18%) (Fig. 2, Table 2 ). Ab NCLMHCn (anti-MHCneonatal) labeled from 0.36 to 1.35% of muscle fibers (Table 2, Fig. 3 ). Most fibers labeled with Abs to MHCembryonic, MHCneonatal, or MHCslow tonic were within the size range of muscle fibers composed of MHCI, MHCIIA, and MHCIIX (C23 lm diameter, see below): for MHCembryonic, 71% of fibers were C23 lm diameter (data for Ab NCL-MHCd); for MHCslow tonic, 97.4% of fibers were C23 lm diameter; and for MHCneonatal, 74% of fibers were C23 lm diameter. Many Ab NCL-MHCn-positive fibers were adjacent to fascicle borders or to spaces devoid of muscle fibers (Fig. 3a) . In occasional fibers sectioned obliquely, reaction with Ab NCL-MHCn was typically localized to the fiber termination (Fig. 3b) .
Muscle Fiber Phenotype Classification and Size Measures
The prevalence and morphometry of muscle fiber phenotypes were determined from 1349 muscle fibers from HG1 (n = 475), HG2 (n = 464), and HG3 (n = 410). These fibers contained only MHCI, MHCIIA, and MHCIIX. Table 3 provides a summary of the fiber counts per 1000 fibers for each phenotype. The most frequent fiber type was MHCIIA, followed by MHCI, MHCI-IIX, MHCI-IIA, and MHCIIX (Fig. 4) . Mean cross-sectional area increased across the five phenotype groups (MHCI, MHCI-IIA, MHCI-IIX, MHCIIA, and MHCIIX) (p = 0.027, test for linear trend; Fig. 5 ). The diameter also increased across the five phenotype groups (p = 0.0013, test for linear trend). A similar linear trend was identified for perimeter (p = 0.0055).
Immunoblot Identification of MHC Isoforms
MHCembryonic, MHCneonatal, and MHCslow tonic were demonstrated in positive control tissue (FT and MR) but were not demonstrated in human HG or BB (Fig. 6) .
Discussion
Summary
The primary finding of this study is that the human HG is composed of MHCI, MHCIIA, and MHCIIX isoforms and does not contain MHCembryonic, MHCneonatal, or MHCslow tonic in more than occasional fibers. A secondary finding is that the majority of HG muscle fibers are composed of either slow (MHCI) or fast (MHCIIA, possibly MHCIIA-IIX) isoforms, and that slow-fast hybrids account for less than 26% of muscle fibers. In MHC phenotype composition, the human HG is thus similar to human appendicular muscles and many human head and neck muscles but different from a handful of human head and neck muscles which express MHCembryonic, MHCneonatal, and MHCslow tonic in an appreciable number of fibers.
Comparison to Other Human Tongue Muscles
The present findings are generally similar to reports of MHC composition and muscle fiber type (by ATPase) in other human tongue muscles. In our study of the human styloglossus [27] , we found few or no fibers positive for MHCembryonic or MHCneonatal. MHC phenotype prevalence was also ranked MHCII [ MHCI [ MHCI-II (although hybrid fibers were less common, MHCI-II, 17%), and ranking of fiber size by phenotype (MHCII [ MHCI-II [ MHCI) was the same as in the current study. In a previous study, appreciable MHCslow tonic was not present in human tongue muscles genioglossus, HG, superior longitudinalis, transversus, and verticalis [41] . In human intrinsic tongue muscles, Stal et al. [26] reported positive reaction with Abs to MHCII and MHCI as well as regional variation of fiber type prevalence, with prevalence of Type IIA highest in anterior tongue regions (57-59%) and of Type I highest in posterior regions (46-58%). Prevalence of Type IM/IIC fibers (which reacted with Abs for both MHCI and MHCII) was 4-8% in anterior and middle regions but 20% in posterior regions. Thus, compared with anterior and middle intrinsic tongue muscles, posterior intrinsic muscles, the HG, and the styloglossus share a relatively high prevalence of slow-fast hybrid fibers and thus presumably increased diversity in muscle fiber contractile properties. Saigusa et al. [47] noted greater prevalence of Type I fibers in posterior (51%) versus anterior (31.3%) genioglossus regions but did not report IM/IIC. Size measures for the HG (average diameter = 56.4 lm) are similar to those for styloglossus [27] and posterior intrinsic tongue muscles (47 lm) [26] , but much greater than measures for genioglossus (by region, 19.2-25.7 lm) [47] . 
Comparison to Other Human Cranial Muscles
The extent of MHC diversity in human cranial muscles is currently a subject of some contention [20, 21, 41, 45, 48, 49] . In human extraocular muscle, MHCeom, MHCacardiac, MHCneonatal, and MHCslow tonic are each expressed in many muscle fibers [16] [17] [18] . Appreciable expression (i.e., each MHC expressed in [5% fibers) is reported for MHCneonatal in the masseter [45, 48] , medial pterygoid [48] , sternohyoid [48] , and temporalis [45, 50] and for MHCacardiac in the digastric [48] , geniohyoid, [48] , lateral pterygoid [45, 48] , masseter [48, 51] , medial pterygoid [48] , and temporalis [45, 48] . In other muscles tested, however, studies report few or no fibers positive for MHCneonatal (e.g., digastric [45, 48] , cricopharyngeus, [49] , geniohyoid [45] , interarytenoid [52] , levator veli palatini [53] , palatopharyngeus [53] , pharyngeal constrictor [49] , posterior cricoarytenoid, [38] , lateral pterygoid [45] , sternohyoid [54] , tensor veli palatini [53] , styloglossus [27] , thyroarytenoid [54] , uvula [53] , zygomaticus major/ minor [55] ), few or no fibers positive for MHCacardiac (e.g., digastric [45] , levator veli palatini [53] , masseter [45, 55] , mylohyoid [48] , obicularis oris [55] , palatopharyngeus [53] , posterior cricoarytenoid, [38] , tensor veli palatini [53] , uvula [53] zygomaticus major/minor [55] ), few or no fibers positive for MHCslow tonic (e.g., anterior digastric [41] , genioglossus [41] , geniohyoid [41] , hyoglossus [41] , intrinsic tongue muscles [41] , levator veli palatini [53] , masseter [55] , mylohyoid [41] , palatopharyngeus [53] , posterior cricoarytenoid [38] , styloglossus [41] , tensor veli palatini [53] , thyroarytenoid [54] , zygomaticus major/ minor [55] ), and few or no fibers positive for MHCembryonic (e.g., digastric [45] , levator veli palatini [53] , masseter [45, 55] , mylohyoid [20] , obicularis oris [55] , palatopharyngeus [53] , lateral pterygoid [45] , tensor veli palatini [53] , uvula [53] , and zygomaticus major/minor [55] ). A conclusion from these studies is that appreciable expression of less common MHC (i.e., MHCacardiac, MHCembryonic, MHCneonatal, and MHCslow tonic) is a feature of only a few human head and neck muscles (primarily human extraocular muscles and muscles of mastication). In contrast to this conclusion are recent reports of abundant MHCacardiac and MHCslow tonic in human digastric [21] and abundant MHCacardiac, MHCneonatal, and MHCslow tonic in human mylohyoid, cricopharyngeus, inferior pharyngeal constrictor, and upper esophagus [20, 56] . Because discordant reports of MHC composition in the same muscles may reflect differing specificities of Abs used in different studies (e.g., Ab BA-G5 to identify MHCacardiac, Ab ALD-58 to identify MHCslow tonic, and Ab N2.261 to identify MHCneonatal in [20, 21, 56] versus Abs F88112F8 and 249-5A4 to identify MHCacardiac, Ab S46 to identify MHCslow tonic, and Abs NN5 and NCL-MHCn to identify MHCneonatal in [41, 48, 49] ), we tested Abs on control tissue sections to establish Ab specificity in our hands. Whereas Abs F1.652, NCLMHCd, and NCL-MHCn reacted with fetal but not adult Figs. 1 and 2 ; see also [31, 39] ). In adult human tissue, Ab 4A6 reacted exclusively with putative MHCeom in human extraocular muscle and Ab S46 reacted exclusively with putative MHCslow tonic in extraocular muscle and muscle spindles (we did not test for MHCacardiac). Based on these findings, we tested for MHCeom, MHCembryonic, MHCneonatal, and MHCslow tonic in HG with Abs 4A6, F1.652, NCL-MHCd, NCL-MHCn, and S46; no or few fibers were labeled with these Abs. We conclude that there is no appreciable MHCeom, MHCembryonic, MHCneonatal, or MHCslow tonic in the human HG and that despite the activation of the HG in behaviors with different tongue movement speeds and diverse tongue shape changes, expression of multiple, uncommon MHC is not required for normal HG function. We also suggest that recent reports of abundant MHCneonatal and MHCslow tonic (and possibly MHCacardiac) in human digastric, mylohyoid, cricopharyngeus, inferior pharyngeal constrictor, and upper [41] . In adult vertebrates, developmental MHC is present in muscles in a number of pathologic [59] [60] [61] and experimental [62] [63] [64] conditions. Expression of developmental MHC in these conditions is typically considered to be associated with muscle fiber atrophy, denervation, regeneration, and/or remodeling [59, 63, 65] ; muscle fibers positive for developmental MHC range in size but commonly are very small [61, 64] . In addition, in normal adult vertebrate muscle, MHCembryonic may be expressed at myotendinous junctions ( [35] ; for expression at myotendinous junctions following muscle loading see [66] ) and MHCneonatal at muscle fiber terminations ( [67] ; for expression at myotendinous junctions following muscle stretch see [68] ). Expression of MHCneonatal at muscle fiber terminations has been studied most extensively in the avian pectoralis (67, 69) , a muscle of in-series design (i.e., primarily comprised of short, tapered muscle fibers that overlap from muscle origin to insertion). Reflecting the elongated tapered morphology of constituent muscle fibers, most MHCneonatal-positive fibers are very small and react for MHCneonatal in many serial tissue sections [69] .
In the human HG, fibers positive for MHCembryonic were few (0.0-0.13%) and predominantly of normal size, suggesting, by the criteria of MHCembryonic and fiber size, very limited muscle fiber regeneration or remodeling in our HG sample. Muscle fibers positive for MHCneonatal were more common (0.35-1.35%) but also predominantly of normal size. Although we cannot rule out a pathologic basis for MHCneonatal in our sample, the normal size of most MHCneonatal-positive fibers, the location of MHCneonatal fibers adjacent to fascicle borders and regions devoid of muscle fibers, and the terminal localization of MHCneonatal in most obliquely sectioned muscle fibers suggest that MHCneonatal in the human HG is expressed primarily at muscle fiber terminations (see [52] for a similar suggestion in the human interarytenoid muscle). To our knowledge, the architecture of human HG muscle fibers has not been described, but from these findings we hypothesize that most human HG muscle fibers have blunt terminations. Blunt terminations are present in more than 99% of fibers in the human tongue muscle superior longitudinalis [70] . We also suggest that findings of occasional fibers positive for MHCneonatal and low levels of MHCneonatal mRNA in other nonpathologic head and neck muscles [48, 49, 51, 71] may at least partially reflect the expression and sampling of MHCneonatal at muscle fiber Fig. 5 Mean muscle fiber cross-sectional area (CSA) and 95% confidence intervals for myosin heavy chain (MHC) phenotypes in the human hyoglossus muscle Fig. 6 Immunoblots of human biceps brachii, hyoglossus (HG2, HG4), and fetal tongue (top three panels) and biceps brachii, hyoglossus (HG2, HG4), and medial rectus (bottom panel). Abs NCL-MHCd and NCL-MHCn react with fetal tongue but not biceps brachii or hyoglossus. Ab N2.261 reacts with all tissue. Ab S46 reacts exclusively with medial rectus terminations and not solely the specialization of muscle fiber phenotype.
